Total submissions: 17
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000172001 | SCV000050978 | uncertain significance | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Ambry Genetics | RCV000244350 | SCV000319141 | likely benign | Cardiovascular phenotype | 2013-11-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Eurofins Ntd Llc |
RCV000276961 | SCV000341229 | likely benign | not specified | 2016-04-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000172001 | SCV000513495 | likely benign | not provided | 2021-03-24 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 23861362, 19638735, 28679633) |
Invitae | RCV001086138 | SCV000559831 | benign | Charcot-Marie-Tooth disease type 2 | 2024-01-15 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000276961 | SCV000595593 | likely benign | not specified | 2016-06-16 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000771177 | SCV000903109 | benign | Cardiomyopathy | 2018-07-10 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000172001 | SCV001147459 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | LMNA: BP4, BP7 |
CHEO Genetics Diagnostic Laboratory, |
RCV000771177 | SCV001333641 | benign | Cardiomyopathy | 2018-02-07 | criteria provided, single submitter | clinical testing | |
Molecular Genetics Laboratory, |
RCV001172634 | SCV001335697 | likely benign | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing | ||
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000276961 | SCV004100125 | benign | not specified | 2023-09-25 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004535167 | SCV004720235 | likely benign | LMNA-related disorder | 2019-04-01 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Clinical Genetics, |
RCV000276961 | SCV001922601 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000172001 | SCV001930758 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000172001 | SCV001958579 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000172001 | SCV001967091 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000172001 | SCV002036965 | likely benign | not provided | no assertion criteria provided | clinical testing |